Merrill Lynch v. Flanders-BordenMerrill Lynch v. Flanders-Borden
*1 United States Court of Appeals For the First Circuit
No. 20-1942
MERRILL LYNCH, PIERCE, FENNER & SMITH, INC., Plaintiff, Appellee,
v. KATHERINE FLANDERS-BORDEN, Defendant, Appellant,
WILLIAM J. SHERRY; DAVID E. FLANDERS; KARYN S. BEEDY; BRETT L.
PETERSON,
Defendants, Appellees.
APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS [Hon. George A. O'Toole, Jr., U.S. District Judge] Before
Lynch and Kayatta, Circuit Judges, and Laplante, [*] District Judge.
Scott E. Adams for appellant.
Nellie E. Hestin, with whom McGuireWoods LLP was on brief, for appellee Merrill Lynch, Pierce, Fenner & Smith, Inc.
Hilary S. Schultz, with whom Shultz Law, LLP was on brief, for appellees William J. Sherry, David E. Flanders, Karyn S. Beedy, and Brett L. Peterson.
*2 August 26, 2021
*3 KAYATTA , Circuit Judge . This appeal concerns the validity of a Transfer on Death Agreement ("TOD Agreement") executed by Alton L. Flanders, III. The TOD Agreement relates to an account containing a subset of Flanders's assets for which Merrill Lynch, Pierce, Fenner & Smith, Inc. ("Merrill Lynch") acts as custodian. If valid, the TOD Agreement avoids probate of an at-death transfer of the account assets to five designated beneficiaries, as follows: 20% to Flanders's daughter Katherine Flanders-Borden ("Borden"), 20% to Flanders's brother David Flanders ("David"), and 40%, 10%, and 10%, respectively, to three of Flanders's friends -- William Sherry, Karyn Beedy, and Brett Peterson. After Flanders died intestate, David, Sherry, Beedy, and Peterson (the "consenting beneficiaries") consented to the distribution of the account assets per the terms of the TOD Agreement. Borden, however, claimed that Flanders lacked the mental capacity to enter into the TOD Agreement and that all of the assets distributed by the agreement should therefore revert to his estate, of which she is the sole executor and heir.
To resolve the dispute about how the TOD Agreement assets should be distributed, Merrill Lynch commenced this interpleader action, joining Borden and the four consenting beneficiaries as interpleader defendants. Without opposition from any party, Merrill Lynch moved for and obtained a discharge of any and all liability arising from the dispute. The district court *4 subsequently granted summary judgment to the consenting beneficiaries, holding that no reasonable jury could find on the summary judgment record that Borden had met her burden of showing Flanders lacked capacity at the time he entered into the TOD Agreement. After the district court denied Borden's motion for reconsideration, she timely filed this appeal. For the following reasons, we affirm.
I. Borden presents three claims of error on appeal: (1) Flanders's estate should have been joined in this action; (2) the district court applied the wrong state's law in deciding the motion for summary judgment; and (3) the district court erred in granting summary judgment to the consenting beneficiaries. [1] We consider each claim in turn, supplying background facts as necessary along the way.
A.
We begin with Borden's contention that Flanders's estate
is a required party under Rule 19 of the Federal Rules of Civil
Procedure and that remand is therefore required to allow the
joinder of the estate. We normally review Rule 19(a)
determinations for abuse of discretion. See Picciotto v. Cont'l
Cas. Co.,
It hardly bears repeating that as a general matter,
"arguments not raised in the district court cannot be raised for
the first time on appeal." Sierra Club v. Wagner,
Rule 19 is geared toward circumstances "where a lawsuit
is proceeding without a party whose interests are central to the
suit." Bacardi Int'l Ltd. v. V. Suárez & Co.,
A person is a "required party" who must be joined under Rule 19(a) if "in that person's absence, the court cannot accord complete relief among existing parties" or if
that person claims an interest relating to the subject of the action and is so situated that disposing of the action in the person's absence may:
(i) as a practical matter impair or impede the person's ability to protect the interest; or (ii) leave an existing party subject to a substantial risk of incurring double, multiple, or otherwise inconsistent obligations because of the interest.
Fed. R. Civ. P. 19(a)(1)(A) – (B). Flanders's estate satisfies none of these criteria.
First, even in the estate's absence, the court could (and did) accord complete relief among the existing parties: Merrill Lynch, as interpleader plaintiff, was discharged of liability arising from the interpleader action and the underlying dispute, and the court determined the rights under the *7 TOD agreement of all five beneficiaries, each of whom was joined as an interpleader defendant. Aside from baldly asserting that "[a]bsent joinder of the estate, complete relief cannot be granted," Borden develops no argument to the contrary.
Second, even assuming the estate can claim an interest
in the outcome of this dispute despite the fact that it is an
outsider to the TOD Agreement, proceeding in the estate's absence
did not "as a practical matter impair or impede" its ability to
protect that interest. Fed. R. Civ. P. 19(a)(1)(B)(i). We have
explained that where the interests of an absent party are aligned
closely enough with the interests of an existing party, and where
the existing party pursues those interests in the course of the
litigation, the absent party is not required under Rule 19. See
Bacardi, 719 F.3d at 10-12; see also Shearson, 877 F.2d at 135-
36; Fed. Ins. Co. v. Singing River Health Sys.,
In her reply brief, Borden makes a belated attempt to
identify interests that the estate could not protect due to its
absence: "unreleased estate tax liens" on the TOD account assets
and an alleged failure on the part of Merrill Lynch to receive an
"estate tax waiver" as required by the TOD Agreement. Borden
failed to raise these arguments in her opening appellate brief,
and she failed to develop the factual foundation for either
argument: She provided no evidence that the estate is subject to
any estate tax liens or, as required by the TOD Agreement, that an
estate tax waiver is required in Massachusetts. We therefore deem
these arguments waived on appeal. See United States v. Casey, 825
F.3d 1, 12 (1st Cir. 2016) (deeming arguments raised for first
time in reply brief waived); United States v. Zannino,
It is of no help to Borden that she was joined in her
individual capacity, rather than in her capacity as executor of
the estate. Even as "just" an individual, her only interest in
this lawsuit is in advocating for an outcome that redirects the
assets to the estate and ultimately to her as sole heir. In
*9
pragmatic terms, for purposes of this litigation, Borden and the
estate are one: Borden possessed in equal measure every interest
that the estate has in the outcome of this lawsuit, and with no
conflicting interest. Moreover, as an active participant in the
litigation, Borden was aware of the estate's potential interest in
its outcome and was capable, as executor, of asserting that
interest through a motion to intervene. The fact that Borden was
"well aware of this situation," yet "never moved to intervene" on
behalf of the estate, indicates that she did not deem the estate's
"interests substantially threatened by the litigation." United
States v. San Juan Bay Marina, 239 F.3d 400, 406-07 (1st Cir.
2001); see also Singing River Health Sys.,
Borden also argues that joinder is required because the
estate's absence leaves "an existing party subject to a substantial
risk of incurring double, multiple, or otherwise inconsistent
obligations." Fed. R. Civ. P. 19(a)(1)(B)(ii). This is because,
according to Borden, the estate may attempt to "re-litigat[e]
*10
competency."
[2]
Only the consenting beneficiaries and Merrill Lynch
would face such a risk, however, and none of them have complained,
either in the proceedings below or in this court. Indeed, before
us they have vigorously opposed Borden's assertion that the estate
must be joined. Particularly given the nonjurisdictional and
pragmatic nature of Rule 19, see Lincoln Prop. Co. v. Roche, 547
U.S. 81, 90 (2005); Pujol,
Finally, to the extent Borden argues the policy of
judicial efficiency underlying Rule 19 warrants remand for joinder
of the estate, we cannot agree: particularly given the nearly
three years of proceedings in the district court and the fact that
the case has "reached the Court of Appeals," there is "no
reason . . . to throw away a valid judgment." Provident Tradesmens
*12
Bank & Tr. Co.,
B. We consider next Borden's claim that the district court erred by applying Massachusetts law instead of New York law. Borden's argument hinges on the TOD Agreement's choice-of-law provision, which states: "This Agreement shall be governed by, construed, administered, and enforced according to the laws of the State of New York." Appellees urge us to disregard this provision. On this issue, irony reigns. The party challenging the formation of a contract asks us to enforce a provision of that contract, while the parties seeking to enforce the contract disclaim the applicability of that provision.
Irony to one side, Borden simplifies matters for us by
having failed to raise her choice-of-law argument in the district
court. The argument is therefore forfeited, and we need not
consider it. See Sierra Club,
We apply Massachusetts choice-of-law rules to determine
the applicable law. Klaxon Co. v. Stentor Elec. Mfg. Co., 313
U.S. 487, 496 (1941). "Massachusetts will give effect to a choice
of law provision" where doing so is "fair and reasonable." Realty
Fin. Holdings, LLC v. KS Shiraz Manager, LLC,
*14 Here, the TOD Agreement's choice-of-law provision states the agreement will be "governed by, construed, administered, and enforced" according to New York law. But Borden's challenge is to the formation of the contract, and she does not ask us to construe, administer, or enforce the agreement. See Ne. Data Sys., Inc. v. McDonnell Douglas Comput. Sys. Co., 986 F.2d 607, 611 (1st Cir. 1993) ("Because this claim concerns the validity of the formation of the contract, it cannot be categorized as one involving the rights or obligations arising under the contract. Hence, the claim falls outside the contract's choice-of-law provision." (emphasis in original)). The district court therefore committed no plain error in applying Massachusetts law to Borden's claim.
C.
Lastly, we turn to Borden's claim that the district court
improperly granted summary judgment to the consenting
beneficiaries. We review orders granting summary judgment de novo.
Pac. Indem. Co. v. Deming,
As noted above, Borden claims the TOD Agreement is voidable because Flanders lacked capacity to enter into the agreement. The consenting beneficiaries moved for summary judgment, arguing Borden failed to present any evidence regarding Flanders's capacity. The motion was supported by affidavits from each of the consenting beneficiaries and two of Flanders's attorneys.
Borden failed to file a timely opposition. Instead, she filed a motion for enlargement of time. The district court granted Borden a twenty-one-day extension but advised Borden that she "should not expect any further continuances." Borden missed the extended deadline. Over a month late, she filed an "answer" to the motion for summary judgment. A few months later, Borden filed a motion for leave to file an amended opposition to the motion for summary judgment, as well as an "emergency motion" containing "newly uncovered evidence."
Borden's three late filings contained evidence she claimed demonstrated Flanders's incapacity, consisting principally of medical records from Flanders's hospitalization from October 30 to November 16, 2015, four months before Flanders signed the TOD Agreement. According to those records, Flanders had been "more or less appropriately managing his own affairs until" mid-October 2015, when he developed "confusion and hostility/paranoid ideation" towards his caretakers, which led to a brief period of *16 hospitalization on October 19, 2015. The doctors "[s]uspect[ed]" these symptoms were "substance abuse related." Flanders had an "extensive history of substance abuse/alcohol use disorder," a toxicology screen revealed he had been taking "benzodiazepines and opiates," and he had apparently been drinking around "a bottle of wine a day." The doctors "[a]nticipate[d]" Flanders's symptoms would "substantially clear over several days," apparently because Flanders had experienced a "strikingly similar" substance-abuse- related "delirium" a year earlier, but it had cleared in a similar amount of time. The records also contained a "Notice of Determination of Patient Incapacity" dated November 5, 2015. In that document, a doctor determined that Flanders lacked "capacity to make or communicate health care decisions" pursuant to Massachusetts law. See Mass. Gen. Laws ch. 201D, § 6. The doctor described Flanders's incapacity as being caused by "neurocognitive disorder," "irreversible," of "moderate" extent, and of "long term" duration. See id. ("The determination [of patient incapacity] shall . . . contain the attending physician's opinion regarding the cause and nature of the principal's incapacity as well as its extent and probable duration."). Elsewhere, the doctor diagnosed Flanders with "[p]robable major vascular neurocognitive disorder with behavioral disturbance." Before Flanders was discharged to his home, the doctors described him as "alert," "very *17 insightful," and "[a]ware of his discharge plans," but also stated that he had "residual confusion" and "[p]oor judgment and insight."
The district court struck Borden's untimely opposition and denied her subsequent motions; the hospitalization records were therefore not included in the summary judgment record considered by the court. The court then granted the consenting beneficiaries' motion for summary judgment, holding that "[o]n th[e] summary judgment record, no reasonable factfinder could find that at the time of the [TOD Agreement], [Flanders] was incapable of understanding and deciding upon its terms or was unable to act in a reasonable manner in relation to the transaction."
The court explained that its decision was based on the following undisputed facts taken from the affidavits accompanying the consenting beneficiaries' motion. Flanders had expressed to his friends, his brother, and his long-time personal attorney that he did not want to leave his full estate to Borden. To that end, Flanders spent years working with one of his lawyers, Jessie McCann Brescher, to craft an estate plan that would provide for the consenting beneficiaries. He met with Brescher in February 2016 to discuss setting up a TOD account for that purpose. Flanders then "obtained a blank TOD certificate, gathered the information necessary to complete it, including obtaining the mailing addresses and social security numbers for the five people he wanted to name as beneficiaries, and provided the information to Brescher *18 to complete." According to Brescher's affidavit, Flanders signed the TOD certificate in her presence on March 22, 2016, after reading it, indicating he had no questions, and stating that he was signing voluntarily as his free act and deed. Brescher's affidavit states Flanders was "lucid" and "mentally alert" and that she "ha[s] no doubt that [Flanders] understood what he was doing on March 22, 2016 when he signed the TOD Certificate, what the document was designed and intended to accomplish, and to whom he was planning to leave specified portions of his stock." Finally, the court explained that "multiple individuals who were in contact with [Flanders] around the time he signed the TOD Agreement have attested to his mental soundness, and there is no medical evidence in the summary judgment record to the contrary." Although two affiants acknowledged Flanders's two-week hospitalization from October to November 2015, they stated that at all other times he "seemed in full control of his mental faculties" and only took medications prescribed by his doctor.
On appeal, Borden trains her attention on the district court's conclusion that there was no medical evidence in the summary judgment record belying Flanders's mental soundness. Borden does not argue that the court was wrong to exclude her untimely filings. Rather, she suggests that Sherry's affidavit in support of the consenting beneficiaries' motion itself referred to the medical records she sought to introduce. Therefore, according *19 to Borden, the record contained a genuine issue of material fact foreclosing summary judgment. The consenting beneficiaries dispute that Sherry's affidavit referred to those records. They also argue that the medical records Borden relies upon are unauthenticated and constitute inadmissible hearsay. Even assuming the medical records were properly presented to the court for consideration in connection with the summary judgment motion, however, we conclude that they fail to raise a genuine dispute of material fact as to Flanders's contractual capacity.
Under Massachusetts law, a "contract is voidable by a person who, due to mental illness or defect, lacked the capacity to contract at the time of entering into the agreement." Sparrow v. Demonico, 960 N.E.2d 296, 301 (Mass. 2012). Contractual incapacity exists where a party is either "incapable of understanding and deciding upon the terms of the contract," id. (quoting Wright v. Wright, 29 N.E. 380, 381 (Mass. 1885)), or where, "by reason of mental illness or defect, [the person] is unable to act in a reasonable manner in relation to the transaction and the other party has reason to know of his condition," id. at 302 (alteration in original) (quoting Krasner v. Berk, 319 N.E.2d 897, 900 (Mass. 1974)). In either case, "medical evidence is necessary to establish that a person lacked the capacity to contract due to the existence of a mental condition." Id. at 304. "The inquiry as to the capacity to contract focuses on a party's *20 understanding or conduct only at the time of the disputed transaction," id. at 303, and the "burden is on the party seeking to void the contract to establish that the person was incapacitated at the time of the transaction," id. at 301. [6]
Borden's primary argument is that the hospitalization records are evidence of Flanders's mental incapacity; that no witness presented evidence of successful treatment or cure of his conditions; and that a reasonable jury could therefore infer that Flanders was incapacitated at the time he signed the TOD Agreement. Borden does not distinguish between the acute episode of confusion and paranoia induced by substance abuse and the neurocognitive disorder diagnosis. In either case, though, her argument fails.
The relevant inquiry is Flanders's mental state "at the
time of the disputed transaction." Id. 303. Flanders's
hospitalization, however, was four months prior to his execution
*21
of the TOD Agreements. On these facts, that chronology is fatal
to any argument of incapacity based on the substance-abuse-induced
episode of confusion. Perhaps a reasonable jury could infer that
Flanders's confusion persisted for a short time after his
discharge. But a finding that Flanders lacked capacity four months
later, based solely on the acute bout of confusion -- in the face
of uncontroverted evidence of his mental lucidity at all relevant
times, including most importantly during the transaction at issue
-- would amount to mere speculation.
[7]
More is needed to establish
a genuine dispute of material fact, particularly since Borden bears
the ultimate burden on the issue of contractual competence. See
Mariasch v. Gillette Co., 521 F.3d 68, 71 (1st Cir. 2008)
("[S]ummary judgment cannot be defeated by relying on improbable
inferences, conclusory allegations, or rank speculation." (quoting
Ingram v. Brink's, Inc.,
Conversely, and favorably to Borden, we may assume that
a reasonable jury could find that Flanders's "[p]robable,"
neurocognitive disorder persisted at the time he signed the TOD
*22
Agreement, given that his "patient incapacity" was described by
the doctor as "irreversible" and "long term." But Borden makes no
argument that the doctor's determination in November 2015 that
Flanders lacked "capacity to make or communicate health care
decisions" under Massachusetts law means Flanders was
contractually incompetent in March 2016. Nor could she. See Mass.
Gen. Laws ch. 201D, § 6 ("A determination made pursuant to this
section that a principal lacks capacity to make health care
decisions is solely for the purpose of empowering an agent to make
health care decisions pursuant to a health care proxy." (emphasis
added)); Cohen v. Bolduc, 760 N.E.2d 714, 722 n.25 (Mass. 2002)
("A person may be adjudicated legally incompetent to make some
decisions but competent to make others."); Johnson v. Kindred
Healthcare, Inc., 2 N.E.3d 849, 854 n.10 (Mass. 2014) ("The
capacity 'to make treatment decisions' is distinct from the
capacity 'to make informed decisions as to [one's] property or
financial interests.'" (alteration in original) (quoting Cohen,
So, the records get Borden part way, by showing some
form of incapacity and the existence of a mental condition, but a
gap remains between what she shows and what she would like to show
(contractual incapacity). And to close that gap, Borden needs
under Massachusetts law what she clearly does not have -- medical
evidence linking Flanders's neurocognitive disorder to a lack of
contractual capacity at the time he executed the TOD Agreement.
Sparrow, 960 N.E.2d at 304-05. There is no medical evidence at
all, such as expert testimony, connecting Flanders's disorder to
an inability to "understand[] and decid[e] upon the terms of the
contract" or "act in a reasonable manner in relation to the
transaction" at the time he signed the TOD Agreement (or at any
other time). Id. at 301-02 (first quoting Wright,
Nor for that matter does Borden offer circumstantial evidence of symptoms sufficient to suggest that Flanders's neurocognitive disorder in any way manifested in a loss of those abilities around the time Flanders signed the TOD Agreement. Id. at 305. Without such evidence, a jury could only speculate in attempting to determine the disorder's effect, if any, on Flanders's contractual capacity.
Finally, Borden mounts various attacks on the consenting beneficiaries' evidence regarding Flanders's capacity, none of which we find availing. First, Borden argues that Brescher's *24 statements regarding Flanders's capacity at the time he signed the TOD Agreement are speculative. But those statements were based on Brescher's personal observations of Flanders reading and signing the TOD Agreement and her conversations with Flanders during that meeting. Thus, there is nothing speculative about her conclusion that Flanders "understood what he was doing on March 22, 2016 when he signed the TOD Certificate, what the document was designed and intended to accomplish, and to whom he was planning to leave specified portions of his stock."
Second, Borden argues that Brescher's opinion as to Borden's competency must be disregarded because Brescher is not a medical expert. Borden misunderstands the relevant standards. Although medical evidence, as opposed to lay testimony, "is necessary to establish that a person lacked the capacity to contract due to the existence of a mental condition," Sparrow, 960 N.E.2d at 304 (emphasis added), a "non-expert is competent to testify to the physical appearance and condition and acts of a person both for their probative value for the jury and for the purpose of furnishing facts as the basis of hypothetical questions for experts," id. at 305 (quoting Cox v. United States, 103 F.2d
133, 135 (7th Cir. 1939)). A reasonable jury would be entitled to believe Brescher's unrebutted testimony regarding Flanders's condition and acts at the time he signed the TOD Agreement.
Third, Borden argues that the consenting beneficiaries'
evidence only demonstrates that Flanders had "the lesser level of
testamentary capacity, not the higher standard required for
contractual capacity." See Maimonides Sch. v. Coles, 881 N.E.2d
778, 788 (Mass. App. 2008) (describing test for contractual
capacity as "more demanding" than test for testamentary capacity);
compare Palmer v. Palmer, 500 N.E.2d 1354, 1357-58 (Mass. App.
1986) ("Testamentary capacity requires ability on the part of the
testator to understand and carry in mind, in a general way, the
nature and situation of his property and his relations to those
persons who would naturally have some claim to his remembrance";
"freedom from delusion which is the effect of disease or weakness
and which might influence the disposition of his property"; and
"ability at the time of execution of the alleged will to comprehend
the nature of the act of making a will." (quoting Goddard v.
Dupree,
This argument stumbles at the starting blocks: As we
have repeatedly noted, the burden is on Borden to show Flanders
lacked capacity, not on the consenting beneficiaries to show he
had capacity. Sparrow,
Finally, Borden alleges that Sherry "saw a delusional
state that no other witness knew of or revealed," calling into
question the credibility of the other witnesses. This argument is
based on a false premise: Flanders's brother acknowledged in his
affidavit that Flanders was "hospitalized" for "a couple of weeks
in November of 2015," though he stated that "in all the times" he
spoke with Flanders, he "never doubted [Flanders] was in full
control of his mental faculties." More fundamentally, Borden
offers no evidence that the other witnesses were unaware of
Flanders's hospitalization. Borden guesses what a jury might
conclude if Brescher were asked about her knowledge of Flanders's
hospitalization and diagnosis, but Borden -- who bears the burden
of proof -- never deposed Brescher (or any other witness), nor has
she otherwise presented evidence as to Brescher's knowledge. As
*27
a result, we (and the jury) can only speculate on this record as
to both Brescher's knowledge and the import of her knowledge as to
her credibility. Such "unsupported speculation" cannot substitute
for producing "specific facts, in suitable evidentiary form,
to . . . establish the presence of a trialworthy issue." Triangle
Trading Co. v. Robroy Indus., Inc.,
(1st Cir. 2014))); cf. Blanchard v. Peerless Ins. Co., 958 F.2d 483, 490 & n.10 (1st Cir. 1992) (vacating grant of summary judgment where nonmovant pointed to "undisputed evidence from which a jury might reasonably infer that [the witness's] statements as to his subjective intent were motivated by self-interest").
II. For the foregoing reasons, we affirm the judgment of the district court.
Notes
[*] Of the District of New Hampshire, sitting by designation.
[1] At oral argument, Borden expressly waived the challenge made in her opening brief to Merrill Lynch's discharge.
[2] In her reply brief, Borden also asserts that the estate may attempt to relitigate estate tax liens, but that argument is waived for failure to raise it in her opening appellate brief.
[3] Were Borden correct on this point, it would mean that the estate likely has an interest in not being joined.
[4] In describing, and rejecting, Borden's argument, we do not mean to suggest that we agree the estate can sit by without intervening and then claim not to be bound by a ruling against Borden.
[5] Borden argues this exception is limited to claims of fraud,
but the case law speaks broadly of claims challenging "the validity
of the contract's formation." Realty Fin. Holdings, 18 N.E.3d at
355. And Borden's invocation of Lambert v. Kysar,
[6] Borden argues that Sherry admitted he was in a fiduciary
relationship with Flanders and that the consenting beneficiaries
therefore bear the burden of proof. This argument, raised for the
first time in Borden's reply brief, is waived. See United States
v. Tosi,
[7] Nor did Borden provide any evidence to contradict the consenting beneficiaries' testimony that Flanders was apparently "following his doctors' advice and . . . taking only the medications they prescribed."